5 Form 4 filings for SEPN between 2026-07-17 and 2026-08-14, from 4 filers. 5 discretionary (4 sales, 1 purchases). 4 of 5 state a filing-level total, summing to $72,067,278; the rest report only their largest transaction, so the true figure is higher. Prices ran $7 to $50.
| Filed | Filer | Role | Action | Shares largest txn | Price | Filing total | Txns |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | TRV GP V, LLC | 10% Owner | sold | 147,059 | $50.27 | $7,399,858 | 2 |
| 2026-08-14 | RA Capital Nexus Fund III, L.P. | Director | sold | 746,500 | $42.50 | $63,452,500 | 2 |
| 2026-08-13 | Bhatt Elizabeth | President and COO | sold | 25,000 | $44.00 | $1,100,000 | 3 |
| 2026-08-05 | Long Daniel D. | SVP, Drug Discovery | sold | 2,334 | $34.68 | $114,920 | 4 |
| 2026-07-17 | Bhatt Elizabeth | acquired | 4,000 | $6.81 | — | 2 | |
| 5 filings · 4 filers · disclosed totals only | $72,067,278 (4/5) | — | |||||